Hodgkin Lymphoma Archives - Page 9 of 11

Significant disparities have been found in HIV-positive black patients with Hodgkin lymphoma, with regard to both rate of diagnosis and chemotherapy usage.

Lymphoma

ABVD Shows Higher Progression-free Survival in Hodgkin Lymphoma

By

Lourdes Briz

January 4, 2016

Patients with advanced Hodgkin lymphoma treated with BEACOPP or CEC did not show a progression-free survival.

Isabel Cunningham, MD, Cancer Therapy Advisor Advisory Board member, weighs in on recent discoveries

From The Advisory Board

We Can Treat Hodgkin’s Lymphoma Like Melanoma?

By

Isabel Cunningham, MD

September 3, 2015

Isabel Cunningham, MD, Cancer Therapy Advisor Advisory Board member, weighs in on recent discoveries in the treatment of hematologic cancers.

In patients with myelofibrosis treated with ruxolitinib, harboring three or more mutations was inver

Lymphoma

In Stage 1A Hodgkin Lymphoma, Involved-field Radiotherapy Should Be Standard of Care

By

Jason Hoffman, PharmD, RPh

August 5, 2015

Involved-field radiotherapy (IF-RT) should be considered standard of care for stage 1A nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL).

$Obinutuzumab combined with bendamustine improved progression-free survival in rituximab-refractory i$

Lymphoma

Evaluating Evolution of Incidence Rates of Hodgkin Lymphoma Subtypes

July 29, 2015

Recent declines in nodular sclerosis (NS) rates represented true incidence changes in Hodgkin lymphoma (HL).

Hematologic Cancers

Higher Survival with Brentuximab Vedotin After Stem Cell Transplant

March 19, 2015

For Hodgkin’s lymphoma, brentuximab vedotin is associated with improved progression-free survival after autologous stem-cell transplant.

Lymphoma

PET-Adapted Salvage Therapy Achieves Negativity in Hodgkin Lymphoma

February 19, 2015

PET-adapted sequential salvage therapy with brentuximab could optimize chance of cure in relapsed and refractory Hodgkin lymphoma.